Trial · NCT04065841
Results by group160
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 160
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Histological Improvement: Number and Percentage of Participants Who Responded at Week 48 Compared With Baseline | Tropifexor Monotherapy | 6 | Participants | ||
| Histological Improvement: Number and Percentage of Participants Who Responded at Week 48 Compared With Baseline | Licogliflozin Monotherapy | 9 | Participants | ||
| Histological Improvement: Number and Percentage of Participants Who Responded at Week 48 Compared With Baseline | Combination Therapy | 10 | Participants | ||
| Histological Improvement: Number and Percentage of Participants Who Responded at Week 48 Compared With Baseline | Placebo | 4 | Participants | ||
| Number and Percentage of Participants With Resolution of NASH and no Worsening of Fibrosis | Tropifexor Monotherapy | 5 | Participants | ||
| Number and Percentage of Participants With Resolution of NASH and no Worsening of Fibrosis | Licogliflozin Monotherapy | 3 | Participants | ||
| Number and Percentage of Participants With Resolution of NASH and no Worsening of Fibrosis | Combination Therapy | 10 | Participants | ||
| Number and Percentage of Participants With Resolution of NASH and no Worsening of Fibrosis | Placebo | 2 | Participants | ||
| Number and Percentage of Participants Who Achieved Resolution of NASH and no Worsening of Fibrosis OR Improvement in Fibrosis by at Least One Stage Without Worsening of NASH | Tropifexor Monotherapy | 8 | Participants | ||
| Number and Percentage of Participants Who Achieved Resolution of NASH and no Worsening of Fibrosis OR Improvement in Fibrosis by at Least One Stage Without Worsening of NASH | Licogliflozin Monotherapy | 10 | Participants | ||
| Number and Percentage of Participants Who Achieved Resolution of NASH and no Worsening of Fibrosis OR Improvement in Fibrosis by at Least One Stage Without Worsening of NASH | Combination Therapy | 14 | Participants | ||
| Number and Percentage of Participants Who Achieved Resolution of NASH and no Worsening of Fibrosis OR Improvement in Fibrosis by at Least One Stage Without Worsening of NASH | Placebo | 5 | Participants | ||
| Number and Percentage of Participants With at Least One Stage Improvement in Fibrosis | Tropifexor Monotherapy | 6 | Participants | ||
| Number and Percentage of Participants With at Least One Stage Improvement in Fibrosis | Licogliflozin Monotherapy | 10 | Participants | ||
| Number and Percentage of Participants With at Least One Stage Improvement in Fibrosis | Combination Therapy | 11 | Participants | ||
| Number and Percentage of Participants With at Least One Stage Improvement in Fibrosis | Placebo | 4 | Participants | ||
| Number and Percentage of Participants With at Least Two Stage Improvement in Fibrosis Without Worsening of NASH | Tropifexor Monotherapy | 3 | Participants | ||
| Number and Percentage of Participants With at Least Two Stage Improvement in Fibrosis Without Worsening of NASH | Licogliflozin Monotherapy | 4 | Participants | ||
| Number and Percentage of Participants With at Least Two Stage Improvement in Fibrosis Without Worsening of NASH | Combination Therapy | 3 | Participants | ||
| Number and Percentage of Participants With at Least Two Stage Improvement in Fibrosis Without Worsening of NASH | Placebo | 3 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04065841/results